Keywords: لوسمی میلوئید مزمن; Cancer; Chronic myeloid leukemia; CML; Age of diagnosis; Agricultural exposure;
مقالات ISI لوسمی میلوئید مزمن (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: لوسمی میلوئید مزمن; Chronic myeloid leukemia; Suboptimal response; Nilotinib; Imatinib;
Keywords: لوسمی میلوئید مزمن; ALL; acute lymphoid leukemia; AML; acute myeloid leukemia; CLL; chronic lymphoid leukemia; CML; chronic myeloid leukemia; Hb; hemoglobin; WBC; white blood cell;
Keywords: لوسمی میلوئید مزمن; Chronic myeloid leukemia; Tyrosine kinase inhibition; Stem cell transplantation; Prognosis; QPCR;
Keywords: لوسمی میلوئید مزمن; Priapism; Malignant priapism; Leukemic priapism; Chronic myeloid leukemia; Case report;
Keywords: لوسمی میلوئید مزمن; P-glycoprotein (P-gp); Fluorescence microscopy; Electrochemical sensor; Chronic myeloid leukemia; Single-wall carbon nanotube;
Keywords: لوسمی میلوئید مزمن; Chronic myeloid leukemia; Tyrosine kinase inhibitor; Prevalence; Incidence; Relative survival; Chronic diseases; Population aging; Epidemiological transition;
Keywords: لوسمی میلوئید مزمن; 5FU; 5-fluorouracil; 95%CI; 95% confidence interval; AA; amino acid; AFP; alpha fetoprotein; AML; actue myeloid leukemia; Ang2; angiopoietin 2; ATP; adenosine triphosphate; BCLC; Barcelona-Clinic Liver Cancer classification; BSC; best supportive care; CAP
Keywords: لوسمی میلوئید مزمن; AML; acute myeloid leukemia; ChIP; Chromatin immunoprecipitation; CML; chronic myeloid leukemia; ECM; extracellular matrix; GO; gene ontology; CD29/ITGB1; integrin beta 1; HIP1; huntingtin interacting protein; DAB2; disabled homolog 2; SDC1; syndecan 1; L
Keywords: لوسمی میلوئید مزمن; Basophil; mast cell; development; allergy; anaphylaxis; inflammation; autoimmune disease; infection; antigen presentation; IL-4; protease; APC; Antigen-presenting cell; CIU; Chronic idiopathic urticaria; CML; Chronic myeloid leukemia; EoE; Eosinophilic es
Keywords: لوسمی میلوئید مزمن; Tyrosine kinase inhibitor; Chronic myeloid leukemia; Cardiovascular toxicity; Pulmonary toxicity; Metabolic toxicity;
Keywords: لوسمی میلوئید مزمن; AA-PEG; aminoethylanisamide-polyethylene glycol; AD; Alzheimer's disease; BBB; blood-brain barrier; BDNF; brain derived neurotrophic factor; CML; Chronic Myeloid Leukemia; CPPs; cell penetrating peptides; c(RGDyK; cyclo(Arg-Gly-Asp-D-Tyr-Lys) peptide; DSP
Keywords: لوسمی میلوئید مزمن; Chronic Myeloid Leukemia; Epigenetics; Leukemia stem cells; DNA methylation; Histone modifications; Micro RNA; Cancer; Therapies; Chronic phase; Advanced/accelerated phase; Blast phase/crisis;
Keywords: لوسمی میلوئید مزمن; Imatinib; Molecular response; Chronic myeloid leukemia; Q-PCR; Tyrosine kinase inhibitor;
Keywords: لوسمی میلوئید مزمن; Chronic myeloid leukemia; Prostate cancer; Regional variations; Real world evidence; Real world data; Value of medicines; Sustainability;
Keywords: لوسمی میلوئید مزمن; Chronic myeloid leukemia; Tyrosine kinase Inhibitor; Imatinib; BCR-ABL; Molecular response;
Keywords: لوسمی میلوئید مزمن; ALL; acute lymphocytic leukemia; Brms1; breast cancer metastasis suppressor 1; CerS; ceramide synthase; CML; chronic myeloid leukemia; DES; desaturase enzyme; Drp1; dynamin-related protein 1; ER; endoplasmic reticulum; GlcCer; glucosylceramide; GLUT1; glu
Keywords: لوسمی میلوئید مزمن; Cardiotoxicity; Bone marrow transplantation; Speckle-tracking; 3D echocardiography; 2D; Two-dimensional; 3D; Three-dimensional; AML; Acute myeloid leukemia; BEAM; Carmustine, etoposide, cytarabine, and melphalan; BMT; Bone marrow transplantation; Bu-Thio-
Keywords: لوسمی میلوئید مزمن; Adverse events; Chronic myeloid leukemia; Renal toxicity; Tyrosine kinase inhibitors;
Keywords: لوسمی میلوئید مزمن; Chronic myeloid leukemia; Blast crisis; Disease progression mechanisms; Causal modeling; Bayesian networks; Feedback loops; AP; accelerated phase; BC; blast crisis; CHR; complete hematological response; CML; chronic myeloid leukemia; CP; chronic phase; DA
Keywords: لوسمی میلوئید مزمن; AML; acute myeloid leukemia; BRCA; breast cancer; BRCC3; BRCA1/BRCA2-Containing Complex Subunit 3; C; constant; CLL; chronic lymphocytic leukemia; CML; chronic myeloid leukemia; CSC; cancer stem-like cell; EGFR; epidermal growth factor receptor; EMT; epit
Keywords: لوسمی میلوئید مزمن; AC; adenocarcinomas; AdIL-32; adenoviral overexpression of IL-32; AICD; activation-induced cell death; BAVECs; bovine aortic vascular endothelial cells; BLP; bacterial lipoprotein; CML; chronic myeloid leukemia; Con A; concanavalin A; COPD; chronic obstru
Keywords: لوسمی میلوئید مزمن; CML; chronic myeloid leukemia; GIPAP; Glivec International Patient Assistance Program; Chronic myeloid leukemia; Age at diagnosis; Income; Occupation;
Keywords: لوسمی میلوئید مزمن; Chronic myeloid leukemia; Acute erythroid leukemia
Keywords: لوسمی میلوئید مزمن; Acute lymphoblastic leukemia; Chronic myeloid leukemia; Ph+; Relapse; TKIs;
Keywords: لوسمی میلوئید مزمن; CCyR; complete cytogenetic response; CML; chronic myeloid leukemia; G-CSF; granulocyte-colony stimulating factor; GM-CSF; granulocyte-monocyte-colony stimulating factor; HR; high risk; IL; interleukin; INF; interferon; IR; intermediate risk; LR; low risk;
Keywords: لوسمی میلوئید مزمن; Hematopoiesis; Chronic Myeloid Leukemia; Discrete-continuous model; Moran’s process; Peto’s paradox
Keywords: لوسمی میلوئید مزمن; Hematologic malignancies; Pregnancy; Acute leukemias; Chronic myeloid leukemia; Lymphomas
Keywords: لوسمی میلوئید مزمن; Leucemia mieloide crónica; Tratamiento integral; Factores de riesgo cardiovascular; Conferencia de consenso; Chronic myeloid leukemia; Comprehensive treatment; Cardiovascular risk factors; Consensus meeting;
Keywords: لوسمی میلوئید مزمن; Chronic myeloid leukemia; Chronic phase; Mortality; Disease progression; Treatment-related adverse events
Keywords: لوسمی میلوئید مزمن; Chronic myeloid leukemia; Comprehensive treatment; Cardiovascular risk factors; Consensus meeting; Leucemia mieloide crónica; Tratamiento integral; Factores de riesgo cardiovascular; Conferencia de consenso;
Keywords: لوسمی میلوئید مزمن; Chronic myeloid leukemia; Nilotinib; Cardiovascular risk; Prognosis;
Keywords: لوسمی میلوئید مزمن; Chronic myeloid leukemia; Tyrosine kinase inhibitor; Switch; Early molecular response; Deep molecular response;
Keywords: لوسمی میلوئید مزمن; Chronic myeloid leukemia; Atomic force microscopy; Cell mechanics; Personalized medicine; Single cell analysis;
Keywords: لوسمی میلوئید مزمن; Chronic myeloid leukemia; Reactive oxygen species; Combination therapy; Nanoparticles; Lysosomal membrane permeablization; Cathepsin b;
Keywords: لوسمی میلوئید مزمن; Chronic myeloid leukemia; Cytogenetics; FISH; Philadelphia chromosome; Variant rearrangement; Clonal evolution; Tyrosine kinase inhibitors
Keywords: لوسمی میلوئید مزمن; Ab; Abelson; CD; Crohn's disease; CML; Chronic myeloid leukemia; DAI; Disease activity index; DC; Dentritic cell; IBD; Inflammatory bowel disease; IL; Interleukin; LGL; Large granular lymphocytosis; MDA; Malondialdehyde; MPO; Myeloperoxidase; NFкβ; Nucl
Keywords: لوسمی میلوئید مزمن; AA; accelerated approval; ALL; acute lymphoblastic leukemia; CCyR; complete cytogenetic response; CLL; chronic lymphocytic lymphoma; CML; chronic myeloid leukemia; CRC; colorectal carcinoma; CR; complete response; CRi; complete response with incomplete bl
Keywords: لوسمی میلوئید مزمن; Chronic myeloid leukemia; Atrial fibrillation; β-Thalassemia; Decision making; Treatment switch; Patients' decision;
Keywords: لوسمی میلوئید مزمن; Chronic myeloid leukemia; Early molecular response; Prognosis;
Keywords: لوسمی میلوئید مزمن; BCR-ABL1; Chronic myeloid leukemia; Dose intensity; Philadelphia chromosome; Ponatinib; Tyrosine kinase inhibitor;
Keywords: لوسمی میلوئید مزمن; AML; Acute myeloid leukemia; CAS; Cellular apoptosis susceptibility; CLL; Chronic lymphocytic leukemia; CML; Chronic myeloid leukemia; CRM1; Chromosome region maintenance 1; NES; Nuclear export signal; NF-κB; Nuclear factor-κB; NLS; Nuclear localizing s
Keywords: لوسمی میلوئید مزمن; PDCD5; programmed cell death 5; Treg; regulatory T cell; CK2; casein kinase 2; rhPDCD5; recombinant human PDCD5; PDCD5tg; PDCD5 transgenic mice; HDAC3; histone deacetylase 3; CCT; cytosolic chaperonin containing tailless complex polypeptide 1; EAE; autoim
Keywords: لوسمی میلوئید مزمن; AM; adrenomedullin; AMF; autocrine motility factor; AML; acute myeloid leukemia; BCL; B-cell lymphoma; BCR; breakpoint cluster region; BM; bone marrow; CCL; chemokine (CâC motif) ligand; CML; chronic myeloid leukemia; ECM; extracellular matrix; EGF; epi
Keywords: لوسمی میلوئید مزمن; Cancer stem cell; Chemotherapy; Chemoresistance; Targeted therapy; 5-FU; 5-fluorouracil; ABCT; ATP-binding cassette transporter; ALDH; Aldehyde dehydrogenase; AML; Acute myeloid leukemia; ASC; Adult stem cell; BCRP or ABCG; Breast cancer resistance protei
Keywords: لوسمی میلوئید مزمن; AML; acute myeloid leukemia; CI; Confidence Interval; CLL; chronic lymphocytic leukemia; CML; chronic myeloid leukemia; IRB; Institutional Review Board; MDS; myelodysplastic syndrome; Non-CLL; non-chronic lymphocytic leukemia; OR; odds ratio; RADRUE; Real
Keywords: لوسمی میلوئید مزمن; Chronic myeloid leukemia; Adherence; Survey
Keywords: لوسمی میلوئید مزمن; inhibitory kinaz tyrozynowych 2 generacji; przewlekła białaczka szpikowa; leczenieSecond-generation tyrosine kinase inhibitors; Chronic myeloid leukemia; Treatment
Keywords: لوسمی میلوئید مزمن; Chronic myeloid leukemia; Tyrosine kinase inhibitors; Price of drugs; Generic
Keywords: لوسمی میلوئید مزمن; Chronic myeloid leukemia; Allogeneic stem cell transplantation; Donor lymphocyte infusions; Relapse; Graft-versus-host disease; Graft-versus-leukemia